These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23153580)

  • 1. Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
    Aharoni R; Sasson E; Blumenfeld-Katzir T; Eilam R; Sela M; Assaf Y; Arnon R
    Exp Neurol; 2013 Feb; 240():130-44. PubMed ID: 23153580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct pathological patterns in relapsing-remitting and chronic models of experimental autoimmune enchephalomyelitis and the neuroprotective effect of glatiramer acetate.
    Aharoni R; Vainshtein A; Stock A; Eilam R; From R; Shinder V; Arnon R
    J Autoimmun; 2011 Nov; 37(3):228-41. PubMed ID: 21752599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of white matter damage in animal models of multiple sclerosis by magnetization transfer ratio and quantitative mapping of the apparent bound proton fraction f.
    Rausch M; Tofts P; Lervik P; Walmsley A; Mir A; Schubart A; Seabrook T
    Mult Scler; 2009 Jan; 15(1):16-27. PubMed ID: 18971220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI.
    Boretius S; Escher A; Dallenga T; Wrzos C; Tammer R; Brück W; Nessler S; Frahm J; Stadelmann C
    Neuroimage; 2012 Feb; 59(3):2678-88. PubMed ID: 21914485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral glatiramer acetate in experimental autoimmune encephalomyelitis: clinical and immunological studies.
    Teitelbaum D; Aharoni R; Klinger E; Kreitman R; Raymond E; Malley A; Shofti R; Sela M; Arnon R
    Ann N Y Acad Sci; 2004 Dec; 1029():239-49. PubMed ID: 15681762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glatiramer acetate reduces Th-17 inflammation and induces regulatory T-cells in the CNS of mice with relapsing-remitting or chronic EAE.
    Aharoni R; Eilam R; Stock A; Vainshtein A; Shezen E; Gal H; Friedman N; Arnon R
    J Neuroimmunol; 2010 Aug; 225(1-2):100-11. PubMed ID: 20554028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B cells from glatiramer acetate-treated mice suppress experimental autoimmune encephalomyelitis.
    Kala M; Rhodes SN; Piao WH; Shi FD; Campagnolo DI; Vollmer TL
    Exp Neurol; 2010 Jan; 221(1):136-45. PubMed ID: 19879259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
    Levy Barazany H; Barazany D; Puckett L; Blanga-Kanfi S; Borenstein-Auerbach N; Yang K; Peron JP; Weiner HL; Frenkel D
    Exp Neurol; 2014 May; 255():63-70. PubMed ID: 24552689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
    Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
    Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
    Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetization transfer ratio does not correlate to myelin content in the brain in the MOG-EAE mouse model.
    Fjær S; Bø L; Myhr KM; Torkildsen Ø; Wergeland S
    Neurochem Int; 2015; 83-84():28-40. PubMed ID: 25744931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glatiramer acetate.
    Comi G; Moiola L
    Neurologia; 2002 May; 17(5):244-58. PubMed ID: 12031214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combined treatment of Copaxone and Salirasib attenuates experimental autoimmune encephalomyelitis (EAE) in mice.
    Aizman E; Mor A; Chapman J; Assaf Y; Kloog Y
    J Neuroimmunol; 2010 Dec; 229(1-2):192-203. PubMed ID: 20869125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of brain lesions in a mouse model of progressive multiple sclerosis.
    Levy H; Assaf Y; Frenkel D
    Exp Neurol; 2010 Nov; 226(1):148-58. PubMed ID: 20736006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI signature in a novel mouse model of genetically induced adult oligodendrocyte cell death.
    Mueggler T; Pohl H; Baltes C; Riethmacher D; Suter U; Rudin M
    Neuroimage; 2012 Jan; 59(2):1028-36. PubMed ID: 21945466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal damage is reduced following glatiramer acetate treatment in C57/bl mice with chronic-induced experimental autoimmune encephalomyelitis.
    Gilgun-Sherki Y; Panet H; Holdengreber V; Mosberg-Galili R; Offen D
    Neurosci Res; 2003 Oct; 47(2):201-7. PubMed ID: 14512144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective Effect of Glatiramer Acetate on Neurofilament Light Chain Leakage and Glutamate Excess in an Animal Model of Multiple Sclerosis.
    Aharoni R; Eilam R; Lerner S; Shavit-Stein E; Dori A; Chapman J; Arnon R
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone induces reversible clinical and pathological remission and loss of lymphocyte reactivity to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis.
    Chan J; Ban EJ; Chun KH; Wang S; McQualter J; Bernard C; Toh BH; Alderuccio F
    Autoimmunity; 2008 Aug; 41(5):405-13. PubMed ID: 18568646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.